Zenotech Lab.

Zenotech_Lab.03 May 2024

Pharmaceuticals

₹

-1.07 (-1.62%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Zenotech Lab.

Zenotech Lab.

Pharmaceuticals

Zenotech_Lab.03 May 2024

₹

-1.07 (-1.62%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
20-May-2017	R	17:22 Rights Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Zenotech Laboratories Ltd. has fixed the Record date for the purpose of Rights Issue of Equity Shares. The transactions in the equity shares of the Company should be done on ex-rights basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Zenotech Laboratories Ltd. (532039) RECORD DATE 02/06/2017 PURPOSE Issue of 17 (SEVENTEEN) equity shares of Rs. 10/- each on rights basis for cash at premium of Rs. 35/- per share for every 22 (TWENTY TWO) equity shares held. Ex-Right basis from Date & Sett. No. 01/06/2017 DR-043/2017-2018 Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 31/05/2017)	02-Jun-2017	17:22
24-Apr-2024	BC	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/05/2024 inter alia to consider and approve Audited Standalone Financial Results	01-May-2024
17-Jan-2024	BC	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve Unaudited Financial Results for the	29-Jan-2024
19-Oct-2023	BC	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2023 inter alia to consider and approve unaudited financial results for the	30-Oct-2023
01-Sep-2023	BC	The 34th Annual General Meeting of the Company will be held on Friday, September 29, 2023 at 10:30 a.m. IST through Video Conferencing / Other Audio Visual Means. Pursuant to Regulation 34 of SEBI	29-Sep-2023
05-Sep-2023	BC	The 34th Annual General Meeting of the members of Zenotech Laboratories Limited will be held on Friday, September 29, 2023 at 10:30 a.m. IST through Video Conferencing/ Other Audio Visual Means. The	22-Sep-2023

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)35

Ratio17:22

Book Closure

Record Date	Split Date	Purpose
01-May-2024	-	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/05/2024 inter alia to consider and approve Audited Standalone Financial Results
29-Jan-2024	-	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve Unaudited Financial Results for the
30-Oct-2023	-	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2023 inter alia to consider and approve unaudited financial results for the
29-Sep-2023	-	The 34th Annual General Meeting of the Company will be held on Friday, September 29, 2023 at 10:30 a.m. IST through Video Conferencing / Other Audio Visual Means. Pursuant to Regulation 34 of SEBI
22-Sep-2023	01 Jan'1900	The 34th Annual General Meeting of the members of Zenotech Laboratories Limited will be held on Friday, September 29, 2023 at 10:30 a.m. IST through Video Conferencing/ Other Audio Visual Means. The

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Zenotech Laboratories Ltd ₹64.85(-1.07/-1.62%)	64.85	-1.07	395.78	16.97	47.68	4.37
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,561.13	71.45	85.02	20.71
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,246.87	56.07	18.27	1.28
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	115,033.60	54.70	34.98	4.44
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,242.02	27.78	50.95	8.56
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	55,556.96	15.92	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Gross Sales	8.09	9.92	10.51	8.24	9.96	7.78
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	8.09	9.92	10.51	8.24	9.96	7.78
Other Operating Income	1.02	1.02	1.02	1.02	1.02	1.02
Other Income	0.33	0.28	0.19	0.20	0.23	0.16
Total Income	9.43	11.23	11.72	9.46	11.20	8.96
Total Expenditure	6.33	5.68	6.02	5.59	5.94	5.22
PBIDT	3.11	5.55	5.71	3.87	5.26	3.74
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	3.11	5.55	5.71	3.87	5.26	3.74
Depreciation	1.73	1.74	1.81	1.80	1.78	1.80
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.71	0.44	1.06	0.62	-0.18	0.55
Reported Profit After Tax	0.66	3.36	2.83	1.44	3.67	1.38
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.66	3.36	2.83	1.44	3.67	1.38

EPS (Unit Curr.)	0.11	0.55	0.46	0.24	0.60	0.23
EPS (Adj) (Unit Curr.)	0.11	0.55	0.46	0.24	0.60	0.23
Calculated EPS (Unit Curr.)	0.11	0.55	0.46	0.24	0.60	0.23
Calculated EPS (Adj) (Unit Curr.)	0.11	0.55	0.46	0.24	0.60	0.23
Calculated EPS (Ann.) (Unit Curr.)	0.43	2.20	1.86	0.95	2.40	0.91
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.43	2.20	1.86	0.95	2.40	0.91
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	61.03	61.03	61.03	61.03	61.03	61.03
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	38.44	55.95	54.33	46.97	52.81	48.07
PBDTM(%)	38.44	55.95	54.33	46.97	52.81	48.07
PATM(%)	8.16	33.87	26.93	17.48	36.85	17.74

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	61.03	61.03	61.03	61.03	61.03	61.03
Reserves Total	21.24	9.61	-12.62	-11.40	-22.13	-19.01
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	82.27	70.64	48.41	49.63	38.90	42.02
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	6.00	20.66	21.42	20.24	0.00
Total Debt	0.00	6.00	20.66	21.42	20.24	0.00
Total Liabilities	82.27	76.64	69.07	71.05	59.14	42.02
APPLICATION OF FUNDS :
Gross Block	106.78	105.13	101.48	69.52	59.05	56.17
Less : Accumulated Depreciation	41.39	34.22	27.25	20.79	15.94	11.74
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	65.39	70.91	74.23	48.73	43.11	44.43
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	4.98	0.28	2.18	29.08	16.95	2.32
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.06	0.06	0.09	0.58	0.82
Sundry Debtors	3.32	3.93	3.80	1.86	2.36	0.00
Cash and Bank	11.14	2.41	2.46	1.12	13.25	29.16
Loans and Advances	1.80	0.97	1.02	2.63	3.00	1.43
Total Current Assets	16.26	7.37	7.35	5.71	19.19	31.42
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	8.33	7.29	6.51	5.52	7.91	22.68
Provisions	8.27	8.29	8.44	8.50	17.20	16.77
Total Current Liabilities	16.61	15.58	14.95	14.02	25.11	39.45
Net Current Assets	-0.34	-8.21	-7.60	-8.31	-5.91	-8.03
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	17.10	20.41	0.00	0.00	0.00	0.00
Deferred Tax Liability	7.74	8.13	0.00	0.00	0.00	0.00
Net Deferred Tax	9.36	12.28	0.00	0.00	0.00	0.00
Total Assets	79.38	75.26	68.81	69.50	54.15	38.72
Contingent Liabilities	18.14	11.18	10.65	10.66	18.55	22.69

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	2.41	2.46	1.08	13.20	28.40
Net Cash from Operating Activities	20.66	17.67	5.74	11.38	-14.04
Net Cash Used In Investing Activities	-5.82	-1.84	-4.82	-20.79	-16.19
Net Cash Used In Financing Activities	-6.11	-15.87	0.45	-2.70	15.02
Net Inc./Dec In Cash And Cash Equivalents	8.73	-0.04	1.38	-12.11	-15.21
Cash And Cash Equivalents At End Of The Year	11.14	2.41	2.46	1.08	13.20

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

68.84%

FII Shareholding

0.00%

DII Shareholding

0.99%

Public Shareholding

30.17%

**Promoter pledged shareholding 68.84%

About Zenotech Laboratories Ltd

Zenotech Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 395.78 crores. It has reported a sales of Rs. 8.09 crores and a net profit of Rs. 0.66 crores for the quarter ended December 2018. The company management includes Azadar Hussain Khan, Kavita Shah,Jignesh Anantray Goradia,Azadar Hussain Khan,Chintan Jitendra Shah,Abdul Gafoor Mohammad,JAGRUTI PRASHANT SHETH,Rakeshchandra Jagdishprasad Sinha (Zenotech Laboratories Ltd) among others.

Chairman

Azadar Hussain Khan

Registered office

S No 250-252 Turkapally Villag,Shameerpet Mandal RR District,Hyderabad,Telangana,500078

FAX :91-40-23480429

Background

Incorporation Year1989

Face Value₹10

Market Lot1

How to buy Zenotech Lab. shares on nse?

To buy Zenotech Lab. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Zenotech Lab. share price today?

The Zenotech Lab. shares price on nse is Rs.64.85 today.

What is the market cap of Zenotech Lab. shares on BSE ?

The company has a market capitalization of Rs.395.78Cr

What is the PE & PB ratio of Zenotech Lab. shares ?

PE is 47.68 and PB is 4.37

What is the 52 Week High and Low of Zenotech Lab. shares?

Zenotech Lab. stock price high: Rs.81 Zenotech Lab. stock price low: Rs.49.6